Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tjalf Ziemssen
Effect of Natalizumab on Disease Progression in Secondary Progressive Multiple Sclerosis (ASCEND): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial With an Open-Label Extension
The Lancet Neurology
Neurology
Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-Controlled, Phase 2 Trial
The Lancet Neurology
Neurology
Acute Effects of Alemtuzumab Infusion in Patients With Active Relapsing-Remitting MS
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Profiling Individual Clinical Responses by High-Frequency Serum Neurofilament Assessment in MS
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Peripheral Proinflammatory Th1/Th17 Immune Cell Shift Is Linked to Disease Severity in Amyotrophic Lateral Sclerosis
Scientific Reports
Multidisciplinary
Alemtuzumab in the Long-Term Treatment of Relapsing-Remitting Multiple Sclerosis: An Update on the Clinical Trial Evidence and Data From the Real World
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
An Innovative Technique to Assess Spontaneous Baroreflex Sensitivity With Short Data Segments: Multiple Trigonometric Regressive Spectral Analysis
Frontiers in Physiology
Physiology
Determination of Baroreflex Sensitivity During the Modified Oxford Maneuver by Trigonometric Regressive Spectral Analysis
PLoS ONE
Multidisciplinary
Design of a Non-Interventional Post-Marketing Study to Assess the Long-Term Safety and Effectiveness of Ocrelizumab in German Real World Multiple Sclerosis Cohorts – The CONFIDENCE Study Protocol
BMC Neurology
Medicine
Neurology
Sub-Analysis of Geographical Variations in the 2-Year Observational COPTIMIZE Trial of Patients With Relapsing–remitting Multiple Sclerosis Converting to Glatiramer Acetate
BMC Neurology
Medicine
Neurology
1
2
›
